Ironwood Pharmaceuticals | IRWD - Sales Revenues



Ironwood Pharmaceuticals reported $85.24M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Acadia Pharmaceuticals USD 264.6M 20.28M Jun/2025
Agios Pharmaceuticals USD 12.45M 3.75M Jun/2025
Almirall EUR 275M 9.6M Jun/2025
Alnylam Pharmaceuticals USD 773.69M 179.5M Jun/2025
Amarin USD 72.74M 30.72M Jun/2025
Ardelyx USD 97.66M 18.47M Jun/2025
Astellas Pharma JPY 505.79B 46.5B Jun/2025
AstraZeneca USD 14.46B 867M Jun/2025
Charles River Laboratories USD 1.03B 45.8M Jun/2025
Exact Sciences USD 811.1M 104.1M Jun/2025
Halozyme Therapeutics USD 206M 59M Jun/2025
Incyte USD 1.06B 10M Jun/2025
Ironwood Pharmaceuticals USD 85.24M 5.3M Jun/2025
MacroGenics USD 22.24M 2.89M Jun/2025
Moderna USD 142M 34M Jun/2025
Myriad Genetics USD 213.1M 17.2M Jun/2025
Pacira USD 181.1M 12.18M Jun/2025
PTC Therapeutics USD 178.9M 11.1M Jun/2025
Sarepta Therapeutics USD 611.09M 163.81M Jun/2025
Takeda JPY 1.11T 60B Jun/2025
Ultragenyx Pharmaceutical USD 166.5M 27.21M Jun/2025